BC Platforms, a global leader in healthcare data management and analytics, today announced it…
Medexprim is set to showcase its cutting-edge, regulatory-grade multi-imaging and multimodal datasets at RSNA 2023 in Chicago. These datasets will play a pivotal role in advancing medical diagnostics and treatment planning. By encompassing the entire spectrum of imaging data integral to the patient treatment journey, Medexprim positions itself as a comprehensive solution provider capable of addressing a wide array of pathologies dependent on various imaging modalities. From radiology and radiotherapy to nuclear medicine, genomics, and digital pathology, the company’s offerings span the breadth of medical imaging, empowering healthcare professionals and researchers with robust and reliable data for informed decision-making.
Join us at booth #4365.